Brian T Nguyen, DO
Geriatric Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: 557747 · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$593,299 in 2024
Medicaid paid $593,299 for 6,681 billed services this clinician did in 2024, up to 91 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 675 | $423,951 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 282 | $163,477 |
| Return visit (30+ min) | 1,257 | $5,116 |
| Long return visit (40+ min) | 282 | $756 |
| Pain severity quantified; pain present (COA) (ONC) | 150 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 260 | $0 |
| Medication list documented in medical record (COA) | 827 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 16 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 556 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 335 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 483 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 1,301 | $0 |
| 2024 | 6,681 | 18 | 91 | $593,299 |
| 2023 | 2,404 | 13 | 63 | $375,105 |
| 2022 | 1,362 | 7 | 44 | $225,148 |
| 2021 | 144 | 4 | 35 | $35,345 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 569 | $345,843 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 42 | $24,205 |
| Return visit (30+ min) | 1,058 | $4,982 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 39 | $74 |
| Advance Care Planning discussed and documented advance care plan or surrogate decision maker documented in the medical record (DEM) (GER, Pall Cr) | 14 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 106 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 80 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 60 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 76 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 268 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 47 | $0 |
| Short return visit (20+ min) | 28 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 380 | $224,990 |
| Return visit (30+ min) | 648 | $158 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 86 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 46 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 158 | $0 |
| Short return visit (20+ min) | 28 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 60 | $35,345 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 17 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 23 | $0 |
| Return visit (30+ min) | 44 | $0 |
Drugs they prescribed that Part D paid
$397,363
Pharmacies billed $397,363 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (27 of 3,718) in 2024. At or below the middle of the specialty; the typical geriatric medicine clinician is at 2%.
3,211 generic and 487 brand-name prescriptions · $397,363 in drug cost · 73 antibiotic prescriptions to 43 people · 39 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 35 | $49,630 | $1,418 |
| Jardiance | 24 | $37,787 | $1,574 |
| Tradjenta | 38 | $36,138 | $951 |
| Linzess | 32 | $35,137 | $1,098 |
| Trulicity | 26 | $23,107 | $889 |
See all 77 drugs
| Eliquis | 35 | $49,630 | $1,418 |
| Jardiance | 24 | $37,787 | $1,574 |
| Tradjenta | 38 | $36,138 | $951 |
| Linzess | 32 | $35,137 | $1,098 |
| Trulicity | 26 | $23,107 | $889 |
| Xarelto | 13 | $22,542 | $1,734 |
| Myrbetriq | 30 | $18,145 | $605 |
| Gemtesa | 11 | $8,341 | $758 |
| Rivastigmine | 40 | $8,213 | $205 |
| Spiriva Respimat | 12 | $6,044 | $504 |
| Incruse Ellipta | 13 | $4,133 | $318 |
| Lidocaine | 28 | $3,449 | $123 |
| Sps | 18 | $3,150 | $175 |
| Mirtazapine | 71 | $2,753 | $39 |
| Rivastigmine | 29 | $1,824 | $63 |
| Diclofenac | 77 | $1,746 | $23 |
| Fluticasone-Salmeterol | 17 | $1,652 | $97 |
| Memantine | 56 | $1,595 | $28 |
| Gabapentin | 115 | $1,536 | $13 |
| Donepezil | 156 | $1,431 | $9 |
| Losartan | 127 | $1,272 | $10 |
| Fluocinonide | 17 | $1,217 | $72 |
| Atorvastatin | 179 | $1,141 | $6 |
| Tamsulosin | 56 | $1,043 | $19 |
| Albuterol Sulfate Hfa | 36 | $994 | $28 |
| Sertraline | 165 | $756 | $5 |
| Amlodipine Besylate | 213 | $708 | $3 |
| Metoprolol | 51 | $686 | $13 |
| Trazodone | 101 | $680 | $7 |
| Glipizide | 24 | $672 | $28 |
| Bumetanide | 11 | $648 | $59 |
| Hydralazine | 43 | $601 | $14 |
| Ipratropium | 22 | $596 | $27 |
| Fluticasone Propionate | 72 | $545 | $8 |
| Potassium Chloride | 20 | $537 | $27 |
| Levothyroxine | 44 | $512 | $12 |
| Omeprazole | 56 | $494 | $9 |
| Metformin | 71 | $471 | $7 |
| Pregabalin | 16 | $448 | $28 |
| Valsartan | 14 | $434 | $31 |
| Duloxetine | 30 | $426 | $14 |
| Furosemide | 55 | $417 | $8 |
| Buspirone | 34 | $401 | $12 |
| Carbidopa-Levodopa | 12 | $363 | $30 |
| Lisinopril | 51 | $362 | $7 |
| Pantoprazole | 46 | $355 | $8 |
| Citalopram Hbr | 41 | $353 | $9 |
| Rosuvastatin | 22 | $316 | $14 |
| Metoprolol | 40 | $301 | $8 |
| Finasteride | 29 | $300 | $10 |
| Alendronate | 47 | $284 | $6 |
| Hydrocodone-Acetaminophen | 21 | $281 | $13 |
| Hydrocortisone | 24 | $246 | $10 |
| Quetiapine | 30 | $233 | $8 |
| Hydroxyzine | 11 | $220 | $20 |
| Famotidine | 30 | $217 | $7 |
| Escitalopram | 13 | $200 | $15 |
| Triamcinolone Acetonide | 33 | $187 | $6 |
| Simvastatin | 32 | $169 | $5 |
| Pravastatin | 16 | $159 | $10 |
| Mupirocin | 30 | $149 | $5 |
| Chlorhexidine Gluconate | 36 | $147 | $4 |
| Metformin Hcl Er | 19 | $135 | $7 |
| Baclofen | 11 | $133 | $12 |
| Carvedilol | 25 | $124 | $5 |
| Fluoxetine | 12 | $121 | $10 |
| Atenolol | 24 | $116 | $5 |
| Azithromycin | 21 | $115 | $5 |
| Hydrochlorothiazide | 32 | $108 | $3 |
| Lactulose | 18 | $103 | $6 |
| Isosorbide Mononitrate Er | 16 | $102 | $6 |
| Cephalexin | 25 | $95 | $4 |
| Montelukast | 13 | $93 | $7 |
| Clopidogrel | 12 | $60 | $5 |
| Spironolactone | 17 | $60 | $4 |
| Ondansetron | 12 | $39 | $3 |
| Paxlovid | 13 | $0 | $0 |
Year by year
| 2024 | 3,718 | 311 | 1% (27) | 13% | $397,363 |
| 2023 | 2,803 | 250 | 1% (27) | 14% | $355,409 |
| 2022 | 1,942 | 221 | 2% (33) | 12% | $176,911 |
| 2021 | 317 | 74 | None | 9% | $12,969 |
| 2020 | 72 | 30 | 0% (0) | None | $2,118 |
| 2019 | 107 | 39 | None | 17% | $3,694 |
| 2018 | 113 | 55 | None | None | $2,564 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 68 drugs
| Eliquis | 27 | $44,142 | $1,635 |
| Xarelto | 22 | $30,357 | $1,380 |
| Jardiance | 23 | $29,627 | $1,288 |
| Linzess | 12 | $19,484 | $1,624 |
| Trulicity | 15 | $19,223 | $1,282 |
| Tradjenta | 16 | $17,646 | $1,103 |
| Novolog Flexpen | 28 | $11,428 | $408 |
| Spiriva Respimat | 12 | $5,905 | $492 |
| Diclofenac | 120 | $5,479 | $46 |
| Advair Diskus | 17 | $5,418 | $319 |
| Rivastigmine | 19 | $4,049 | $213 |
| Atorvastatin | 130 | $2,486 | $19 |
| Amlodipine Besylate | 155 | $2,422 | $16 |
| Losartan | 108 | $2,200 | $20 |
| Rivastigmine | 11 | $2,118 | $193 |
| Mirtazapine | 28 | $2,002 | $71 |
| Tamsulosin | 49 | $1,962 | $40 |
| Gabapentin | 68 | $1,937 | $28 |
| Ramelteon | 11 | $1,863 | $169 |
| Quetiapine | 29 | $1,826 | $63 |
| Metformin | 75 | $1,806 | $24 |
| Donepezil | 84 | $1,597 | $19 |
| Valsartan | 11 | $1,383 | $126 |
| Bumetanide | 13 | $1,368 | $105 |
| Metoprolol | 48 | $1,174 | $24 |
| Duloxetine | 36 | $1,142 | $32 |
| Sertraline | 47 | $1,105 | $24 |
| Lisinopril | 54 | $1,049 | $19 |
| Omeprazole | 62 | $1,007 | $16 |
| Divalproex | 12 | $959 | $80 |
| Pregabalin | 21 | $899 | $43 |
| Pantoprazole | 51 | $892 | $17 |
| Levothyroxine | 41 | $863 | $21 |
| Trazodone | 60 | $854 | $14 |
| Hydralazine | 44 | $806 | $18 |
| Simvastatin | 45 | $739 | $16 |
| Finasteride | 35 | $727 | $21 |
| Furosemide | 59 | $708 | $12 |
| Hydroxyzine | 17 | $704 | $41 |
| Metoprolol | 30 | $685 | $23 |
| Potassium Chloride | 16 | $634 | $40 |
| Memantine | 20 | $616 | $31 |
| Citalopram Hbr | 43 | $613 | $14 |
| Fluticasone Propionate | 39 | $593 | $15 |
| Ipratropium | 16 | $497 | $31 |
| Famotidine | 11 | $485 | $44 |
| Hydrocodone-Acetaminophen | 18 | $482 | $27 |
| Albuterol Sulfate Hfa | 13 | $474 | $36 |
| Pravastatin | 12 | $407 | $34 |
| Alendronate | 23 | $384 | $17 |
| Glipizide | 25 | $364 | $15 |
| Triamcinolone Acetonide | 37 | $351 | $9 |
| Atenolol | 23 | $349 | $15 |
| Propranolol | 11 | $333 | $30 |
| Clotrimazole | 16 | $318 | $20 |
| Chlorhexidine Gluconate | 33 | $240 | $7 |
| Spironolactone | 16 | $227 | $14 |
| Metformin Hcl Er | 13 | $220 | $17 |
| Isosorbide Mononitrate Er | 20 | $220 | $11 |
| Azithromycin | 13 | $218 | $17 |
| Hydrochlorothiazide | 19 | $199 | $10 |
| Clonidine | 12 | $188 | $16 |
| Hydrocortisone | 11 | $179 | $16 |
| Mupirocin | 16 | $177 | $11 |
| Clopidogrel | 20 | $154 | $8 |
| Fluoxetine | 11 | $151 | $14 |
| Cephalexin | 20 | $145 | $7 |
| Oxybutynin Chloride Er | 14 | $143 | $10 |
2022: 49 drugs
| Eliquis | 17 | $24,469 | $1,439 |
| Xarelto | 14 | $22,452 | $1,604 |
| Jardiance | 17 | $13,657 | $803 |
| Novolog Flexpen | 17 | $9,732 | $572 |
| Spiriva Respimat | 12 | $5,798 | $483 |
| Advair Diskus | 14 | $4,396 | $314 |
| Diclofenac | 76 | $2,015 | $27 |
| Memantine | 23 | $1,324 | $58 |
| Duloxetine | 22 | $1,166 | $53 |
| Amlodipine Besylate | 130 | $1,110 | $9 |
| Tamsulosin | 35 | $1,104 | $32 |
| Atorvastatin | 77 | $1,086 | $14 |
| Losartan | 70 | $1,003 | $14 |
| Bumetanide | 12 | $988 | $82 |
| Mirtazapine | 18 | $891 | $50 |
| Omeprazole | 77 | $791 | $10 |
| Gabapentin | 39 | $763 | $20 |
| Levothyroxine | 34 | $758 | $22 |
| Donepezil | 82 | $687 | $8 |
| Ventolin Hfa | 11 | $619 | $56 |
| Clotrimazole | 25 | $619 | $25 |
| Metoprolol | 39 | $572 | $15 |
| Sertraline | 40 | $490 | $12 |
| Furosemide | 53 | $470 | $9 |
| Albuterol Sulfate Hfa | 12 | $440 | $37 |
| Hydrocodone-Acetaminophen | 24 | $423 | $18 |
| Metformin | 50 | $415 | $8 |
| Fluticasone Propionate | 35 | $354 | $10 |
| Metoprolol | 19 | $339 | $18 |
| Trazodone | 28 | $337 | $12 |
| Simvastatin | 45 | $319 | $7 |
| Pantoprazole | 15 | $302 | $20 |
| Finasteride | 17 | $282 | $17 |
| Pravastatin | 14 | $271 | $19 |
| Lisinopril | 37 | $269 | $7 |
| Citalopram Hbr | 32 | $268 | $8 |
| Hydralazine | 18 | $244 | $14 |
| Quetiapine | 16 | $241 | $15 |
| Glipizide | 22 | $235 | $11 |
| Atenolol | 18 | $230 | $13 |
| Clopidogrel | 12 | $195 | $16 |
| Chlorhexidine Gluconate | 32 | $184 | $6 |
| Alendronate | 15 | $178 | $12 |
| Triamcinolone Acetonide | 12 | $175 | $15 |
| Spironolactone | 13 | $161 | $12 |
| Famotidine | 13 | $99 | $8 |
| Hydrochlorothiazide | 12 | $89 | $7 |
| Paxlovid (Eua) | 16 | $86 | $5 |
| Cephalexin | 17 | $76 | $4 |
2021: 9 drugs
| Diclofenac | 18 | $369 | $21 |
| Potassium Chloride | 14 | $252 | $18 |
| Sertraline | 22 | $179 | $8 |
| Atorvastatin | 19 | $179 | $9 |
| Amlodipine Besylate | 28 | $174 | $6 |
| Metformin | 11 | $143 | $13 |
| Levothyroxine | 11 | $115 | $10 |
| Pravastatin | 11 | $94 | $9 |
| Furosemide | 12 | $71 | $6 |
2018: 2 drugs
| Cefdinir | 12 | $174 | $14 |
| Prednisone | 16 | $31 | $2 |
Money from drug and device companies
$494 in 2024
| 2024 | 4 | 4 | None | $494 |
| 2023 | 1 | 1 | None | $122 |
| 2022 | 1 | 2 | None | $183 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Austedo Xr | $139 | 1 payment
|
| Kyowa Kirin | Nourianz | $131 | 1 payment
|
| Genzyme | Dupixent | $119 | 1 payment
|
| Dexcom | Dexcom G7 Gss (161) | $105 | 1 payment
|
See all 4 published payments
| Dexcom | Meals · 2024-11-12 | Dexcom G7 Gss (161) | $105 |
| Teva Pharmaceuticals USA | Meals · 2024-05-01 | Austedo Xr | $139 |
| Kyowa Kirin | Meals · 2024-04-18 | Nourianz | $131 |
| Genzyme | Meals · 2024-03-07 | Dupixent | $119 |
See earlier years (2023, 2022)
2023: $122
| Novo Nordisk | Wegovy | $122 | 1 payment
|
2022: $183
| Novo Nordisk | Rybelsus | $183 | 2 payments
|
Professional record
- NPI
- 1598299471
- Licence
- CA 20A18858
- Trained
- Des Moines University of Osteopathic Medicine and Health Sciences, 2017
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207QG0300X (207QG0300X)
- Mailing address
- 1155 Mill St # 11, Reno, NV, 89502
- NPI first listed
- 2017-04-17
- NPI last updated
- 2022-09-23
- NPI record certified
- 2022-09-23
This is when the NPI record was last certified, not a medical board exam.